Lv71
4680 积分 2024-01-26 加入
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
1个月前
已完结
TrkB transmembrane domain: bridging structural understanding with therapeutic strategy
2个月前
已完结
Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease
3个月前
已完结
Translating TRAIL-receptor targeting agents to the clinic
3个月前
已完结
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
4个月前
已完结
E2025, a novel anti‐EphA4 antibody, enhances EphA4 cleavage, and suppresses tau pathologies in a transgenic model of AD
7个月前
已完结
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer’s disease
7个月前
已完结
Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeutics
7个月前
已完结
Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors
7个月前
已完结
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
7个月前
已完结
皖公网安备34019202002308
